Tobacco Use and Cessation, HIV, and TB in South Africa: Clinical and Economic Outcomes

南非的烟草使用和戒烟、艾滋病毒和结核病:临床和经济成果

基本信息

  • 批准号:
    10668251
  • 负责人:
  • 金额:
    $ 61.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Global health organizations have called for integrating tobacco control into HIV and tuberculosis (TB) responses. Tobacco use worsens health outcomes of people with HIV, including conferring higher risks of TB and of noncommunicable diseases such as cardiovascular disease and cancer. How to most effectively and efficiently incorporate tobacco control into HIV and TB care remains unclear; resource constraints necessitate thoughtful and evidence-based planning. Determining which interventions are most effective and cost-effective, and how to combine delivery approaches for optimal outcomes, is critically important for informing clinical guidelines. This requires understanding the benefits and costs of various interventions, which cost- effectiveness modeling is specifically designed to address. The overall goal of this proposal is to promote an evidence-based approach to decisions surrounding the integrated care and services for the overlapping tobacco, HIV, and TB epidemics in low- and middle-income countries (LMICs). Tobacco use and cessation behaviors in LMICs may differ from those in high-income countries and can influence the effectiveness of interventions. In this proposal, we will focus on South Africa, a country with colliding tobacco, HIV, and TB epidemics. Our research plan includes: developing an integrated simulation model of tobacco, HIV, and TB; parameterizing the model with behavioral, clinical, and cost data from a community-based population cohort in South Africa and from other databases and studies; projecting clinical and economic outcomes associated with tobacco use and cessation among people with HIV; and conducting model-based cost-effectiveness analysis of tobacco cessation interventions, including those combined with other HIV and TB care interventions. This proposal brings together internationally recognized experts in fields that are complementary for the project, including clinical policy-relevant HIV and TB simulation modeling, health behaviors, tobacco treatment interventions, and epidemiology of HIV and comorbidities in South Africa. The investigators and institutions have a history of highly productive collaboration. The innovative model will be the first to integrate tobacco, HIV, and TB. The methods are highly significant and crucial for addressing questions around cost- effectiveness and policies for integrating tobacco cessation with HIV and TB care. The model structure will enable future analyses of tobacco cessation interventions in other settings, establishing a broad, durable framework for policy-relevant clinical and health economic analyses.
项目总结 全球卫生组织呼吁将烟草控制纳入艾滋病毒和结核病(TB) 回应。烟草使用会恶化艾滋病毒携带者的健康状况,包括增加患结核病的风险 以及心血管疾病和癌症等非传染性疾病的风险。如何最有效地 将烟草控制有效地纳入艾滋病毒和结核病护理仍不清楚;资源限制是必要的 深思熟虑和循证的规划。确定哪些干预措施最有效、最具成本效益, 以及如何结合给药方法以获得最佳结果,对于向临床提供信息至关重要 指导方针。这需要了解各种干预措施的收益和成本,这些成本- 有效性建模是专门设计来解决这些问题的。 这项提案的总体目标是促进以循证方法做出围绕 为低收入和中等收入人群中烟草、艾滋病毒和结核病重叠流行提供综合护理和服务 国家(LMIC)。低收入人群的烟草使用和戒烟行为可能与高收入人群不同 并可能影响干预措施的有效性。在这个提案中,我们将把重点放在南非,一个 烟草、艾滋病毒和结核病疫情频发的国家。我们的研究计划包括:开发集成的 烟草、艾滋病毒和结核病的模拟模型;使用行为、临床和成本数据对模型进行参数化 从南非以社区为基础的人口队列以及其他数据库和研究; 与艾滋病毒感染者使用烟草和戒烟有关的临床和经济后果;以及 对戒烟干预措施进行基于模型的成本效益分析,包括 与其他艾滋病毒和结核病护理干预措施相结合。 这项建议汇集了国际公认的专家,这些领域与 项目,包括与临床政策相关的艾滋病毒和结核病模拟模型、健康行为、烟草治疗 干预措施,以及南非艾滋病毒和共病的流行病学。调查人员和机构 拥有高效合作的历史。这种创新模式将是第一个整合烟草的模式, 艾滋病毒和结核病。这些方法对于解决有关成本的问题非常重要和关键- 将戒烟与艾滋病毒和结核病护理相结合的有效性和政策。模型结构将 能够在其他环境中对戒烟干预措施进行未来分析,建立广泛、持久的 与政策相关的临床和卫生经济分析框架。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The ethics of conducting observational tobacco research without providing treatment to people who use tobacco: a case example from South Africa.
  • DOI:
    10.1136/bmjgh-2022-009732
  • 发表时间:
    2022-07
  • 期刊:
  • 影响因子:
    8.1
  • 作者:
    Kruse, Gina;Zulu, Thando;Ngubane, Hloniphile;Reddy, Krishna;Siedner, Mark;Rigotti, Nancy A.;Seeley, Janet;Ngwenya, Nothando;Wong, Emily
  • 通讯作者:
    Wong, Emily
Tobacco smoking and prevalence of communicable and non-communicable diseases in rural South Africa: A cross-sectional study.
南非农村地区吸烟与传染性和非传染性疾病的流行:一项横断面研究。
  • DOI:
    10.21203/rs.3.rs-2730894/v1
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Chidumwa,Glory;Olivier,Stephen;Ngubane,Hloniphile;Zulu,Thando;Sewpaul,Ronel;Kruse,Gina;Rigotti,NancyA;Siedner,MarkJ;Reddy,KrishnaP;Wong,EmilyB
  • 通讯作者:
    Wong,EmilyB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Krishna P Reddy其他文献

Cost-effective pricing of long-acting injectable HIV pre-exposure prophylaxis for adolescent girls and young women in South Africa: a model-based analysis
南非针对少女和年轻女性的长效注射式艾滋病毒暴露前预防的具有成本效益的定价:基于模型的分析
  • DOI:
    10.1016/s2214-109x(25)00119-6
  • 发表时间:
    2025-07-01
  • 期刊:
  • 影响因子:
    18.000
  • 作者:
    Elena Y Jin;Ali R Ahmed;Linda-Gail Bekker;Elzette Rousseau;Caitlin M Dugdale;Clare F Flanagan;Melissa Wallace;Kenneth A Freedberg;Catherine Orrell;Krishna P Reddy;A David Paltiel;Andrea L Ciaranello;Anne M Neilan
  • 通讯作者:
    Anne M Neilan

Krishna P Reddy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Krishna P Reddy', 18)}}的其他基金

Tobacco Use and Cessation, HIV, and TB in South Africa: Clinical and Economic Outcomes
南非的烟草使用和戒烟、艾滋病毒和结核病:临床和经济成果
  • 批准号:
    10453768
  • 财政年份:
    2020
  • 资助金额:
    $ 61.51万
  • 项目类别:
Tobacco Use and Cessation, HIV, and TB in South Africa: Clinical and Economic Outcomes
南非的烟草使用和戒烟、艾滋病毒和结核病:临床和经济成果
  • 批准号:
    10240721
  • 财政年份:
    2020
  • 资助金额:
    $ 61.51万
  • 项目类别:
Tobacco Use and Cessation, HIV, and TB in South Africa: Clinical and Economic Outcomes
南非的烟草使用和戒烟、艾滋病毒和结核病:临床和经济成果
  • 批准号:
    10080873
  • 财政年份:
    2020
  • 资助金额:
    $ 61.51万
  • 项目类别:
Clinical and Economic Outcomes of HIV, Cigarette Smoking, and Smoking Cessation Interventions
艾滋病毒、吸烟和戒烟干预措施的临床和经济成果
  • 批准号:
    9339641
  • 财政年份:
    2016
  • 资助金额:
    $ 61.51万
  • 项目类别:
Clinical and Economic Outcomes of HIV, Cigarette Smoking, and Smoking Cessation Interventions
艾滋病毒、吸烟和戒烟干预措施的临床和经济成果
  • 批准号:
    9981711
  • 财政年份:
    2016
  • 资助金额:
    $ 61.51万
  • 项目类别:
Novel Methods to Inform HIV/TB Clinical Trial Development
为 HIV/TB 临床试验开发提供信息的新方法
  • 批准号:
    10203771
  • 财政年份:
    2011
  • 资助金额:
    $ 61.51万
  • 项目类别:
Novel Methods to Inform HIV/TB Clinical Trial Development
为 HIV/TB 临床试验开发提供信息的新方法
  • 批准号:
    10686126
  • 财政年份:
    2011
  • 资助金额:
    $ 61.51万
  • 项目类别:
Novel Methods to Inform HIV/TB Clinical Trial Development
为 HIV/TB 临床试验开发提供信息的新方法
  • 批准号:
    9890410
  • 财政年份:
    2011
  • 资助金额:
    $ 61.51万
  • 项目类别:
Novel Methods to Inform HIV/TB Clinical Trial Development
为 HIV/TB 临床试验开发提供信息的新方法
  • 批准号:
    10474351
  • 财政年份:
    2011
  • 资助金额:
    $ 61.51万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 61.51万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.51万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 61.51万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.51万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 61.51万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 61.51万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.51万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 61.51万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 61.51万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.51万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了